Highlights

  • As part of the Phase II/III trial, the two-dose Covaxin was administered to 525 children 28 days apart.
  • Bharat Biotech had received the drug regulators’ nod to conduct the children’s trial in May this year.

Latest news

DC Fandome | 'The Flash' trailer teases fans with Michael Keaton's Batman

DC Fandome | 'The Flash' trailer teases fans with Michael Keaton's Batman

Your heart needs some extra TLC once you reach middle age. This study will set you in the right direction

Your heart needs some extra TLC once you reach middle age. This study will set you in the right direction

Kunal Khemmu wraps up shoot for 'Kanjoos Makkichoos' with Shweta Tripathi

Kunal Khemmu wraps up shoot for 'Kanjoos Makkichoos' with Shweta Tripathi

First film shot in the space: Russian filmmakers land after shoot aboard space station

First film shot in the space: Russian filmmakers land after shoot aboard space station

On camera: four hurt as speeding car rams into Durga procession in Bhopal

On camera: four hurt as speeding car rams into Durga procession in Bhopal

Vaccine for kids: Covaxin gets panel nod for children aged 2-18 years

Subject Expert Committee (SEC) of the drug regulator has recommended granting an emergency use authorisation to Covaxin for 2-18 age group.

Vaccine for children aged 2-18 in sight in India! The Subject Expert Committee (SEC) of the drug regulator has recommended granting an emergency use authorisation to Bharat Biotech's Covaxin for children aged between 2-18. The SEC has submitted its recommendation to the Drugs Controller General of India (DCGI) who will take the final call on the approval and roll-out. 

As part of the Phase II/III trial, the two-dose Covaxin was administered to 525 children 28 days apart. Bharat Biotech had received the drug regulators’ nod to conduct the children’s trial in May this year. 

Also watch: Pfizer covid vaccine likely for kids aged 5-11 in the United States from November first week
Covaxin will become the second vaccine cleared for use on kids in India; in August Zydus Cadila's three-dose DNA jab was allowed to be used on children but only over the age of 12.

A third potential vaccine for kids is Serum Institute's Novavax, for which the DCGI last month cleared trials for children between 7 and 11 years.




Up Next

Vaccine for kids: Covaxin gets panel nod for children aged 2-18 years

Vaccine for kids: Covaxin gets panel nod for children aged 2-18 years

Poonch encounter rages for seventh day, 9 soldiers lost their life: 7 top updates

Poonch encounter rages for seventh day, 9 soldiers lost their life: 7 top updates

Kerala rain fury kills at least 8 people: 10 latest developments

Kerala rain fury kills at least 8 people: 10 latest developments

Singhu border lynching: second Nihang Sikh ‘surrenders’, 2 more held from farmer protest site

Singhu border lynching: second Nihang Sikh ‘surrenders’, 2 more held from farmer protest site

Kerala rain fury kills 6: armed forces on standby but MeT says showers to subside

Kerala rain fury kills 6: armed forces on standby but MeT says showers to subside

Two more target killings in Kashmir: big story in 5 points

Two more target killings in Kashmir: big story in 5 points